Thought Leadership
Email Page
2018 Year-End Roundup of Federal Circuit Obviousness Decisions in Biopharma
April 9, 2019
Jonathan Harris and Drew Hillier
Westlaw Journal Pharmaceutical

Westlaw Journal Pharmaceutical published “2018 Year-End Roundup of Federal Circuit Obviousness Decisions in Biopharma,” authored by Axinn partner Jonathan Harris and associate Drew Hillier.

Click here to access the article. 

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.